Qventus, a US-based developer of management software for healthcare systems, received $30m yesterday in a series B round that included healthcare provider NewYork-Presbyterian Hospital.
Venture capital firms Bessemer Venture Partners, Mayfield Fund and Norwest Venture Partners also participated in the round, and Bessemer partner Stephen Kraus will join Qventus’ board of directors in connection with its investment.
Qventus has developed a software platform that utilises artificial intelligence technology to help hospital staff make effective operational decisions in a wide range of areas in real time.
The company will put the series B funds into the further development of the platform, which is already in use in healthcare systems including NewYork-Presbyterian Hospital.
David Tsay, NewYork-Presbyterian’s associate chief transformation officer, said: “We look forward to expanding the positive impact of intelligent automation in healthcare, and to using technology to improve patient length of stay and other operational advancements.”
The round boosted the company’s overall funding to more than $43m, it said. Norwest and Mayfield co-led its $13m series A round, which included Y Combinator and Stanford-StartX Fund, in late 2016.